Find the Perfect Plan for Your Investment Journey
L
Last Price
52 Week Range
CA$0.01 - CA$0.04
Next Earnings Date
Jul 24 2025 (Estimate)
Next Earnings Date
Jul 24 2025 (Est.)
Last Price
Market Cap | CA$6.41M |
EV | CA$8.27M |
Shares Outstanding | 187.07M |
Beta | 2.00 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | -18.50% |
EPS | 31.50% |
Operating Cash Flow | 51.00% |
Free Cash Flow | 23.50% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
L
Lobe Sciences Ltd.
LOBE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Sancilio, Frederick
Employees
Website
www.lobesciences.comIPO Date
2012-06-28
Headquarters
1199 West Hasting Street, Suite 1400, Vancouver, British Columbia, V6E 3T5, Canada
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved